Mammographic and contrast-enhanced spectral mammography imaging findings of HER2-positive cancers according to hormone receptor status

Mammographic and contrast-enhanced spectral mammography imaging findings of HER2-positive cancers according to hormone receptor status

Abstract Background Breast cancer is the leading cause of cancer-related mortality in women. Human epidermal growth factor receptor 2 (HER2) overexpression is seen in 20 out of 100 invasive breast cancers. Among HER2+ patients, two distinct hormone receptor (HR) subtypes can be defined: HR-positive...

Full description

Bibliographic Details
Main Authors: Hebatalla Elkassas, Maha Hussein Helal, Hisham S. Wahba Mikhael, Rana Khaled, Ahmed Farahat, Samar M. El-Maadawy
Format: Article
Language:English
Published: SpringerOpen 2022-12-01
Series:The Egyptian Journal of Radiology and Nuclear Medicine
Subjects:
Breast neoplasms
Contrast-enhanced spectral mammography
Human epidermal growth factor receptor 2 (HER2)
Immunohistochemistry
Online Access:https://doi.org/10.1186/s43055-022-00933-7

Internet

https://doi.org/10.1186/s43055-022-00933-7

Similar Items